| 3D | 3-dimensional |
| aSMA | alpha smooth muscle actin |
| BM | basement membrane |
| CAF | cancer-associated fibroblast |
| ECM | extracellular matrix |
| EDA-Fn | EDA domain containing fibronectin |
| EDB-Fn | EDB domain containing fibronectin |
| EGF | epidermal growth factor |
| EGFR | epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| Fn | fibronectin |
| FNIII | fibronectin type III-like repeats |
| HD | hemidesmosome |
| HNSCC | head and neck squamous cell carcinoma |
| Ln | laminin |
| Ln332 | laminin 332 |
| Ln5 | laminin 5 |
| Lng2 | laminin gamma 2 chain |
| MMP | matrix metalloproteinase |
| mRNA | messenger RNA |
| myCAF | cancer-associated fibroblast with a myofibroblast phenotype |
| oncf | oncofetal |
| oncfECM | oncofetal extracellular matrix |
| oncfFn | oncofetal fibronectin |
| oncfTn-C | oncofetal tenascin-C |
| OSCC | oral squamous cell carcinoma |
| RNA | ribonucleic acid |
| TGFβ1 | transforming growth factor beta 1 |
| TIMP | tissue inhibitor of metalloproteinases |
| TME | tumor microenvironment |
| Tn-C | tenascin-C |